- West Pharmaceuticals designs and manufactures packaging and delivery systems for various types of medications and pharmaceutical products.
- HealthPrize Technologies addresses medication non-adherence through online and mobile-based programs.
- The two companies are teaming up and integrating their offerings into an end-to-end connected drug delivery system aimed at patients who self-inject their medications, including insulin and various types of biologics, in order to prop up drug regimen adherence.
Despite persistent outcry regarding drug non-adherence over the last 10 years, the issue continues to be a leading cause of poor clinical outcomes and increased healthcare costs. By teaming up with HealthPrize Technologies, West Pharmaceuticals will be able to introduce an element that can increase adherence among patients who rely on its hand-held drug delivery systems, including the SmartDose electronic wearable injector—the first wearable bolus injector to be studied in clinical settings.
Patients using the HealthPrize platform will engage in various games and behavioral economics-based online and mobile interactions that reward them for sticking to their drug regimens—rewards that present themselves, not only in the online setting, but also in terms of personal health outcomes.